| | CASMASCI | progen | BOC | 進口現貨產品 | 胎牛血清 | 細胞培養 | 提取試劑 | 轉染試劑 | 常規生化試劑 | ELISA試劑盒 | 抗體 | 細胞因子 | sigma aldrich(西格瑪) | Invitrogen(英駿) | Millipore | Abcam | CST | Roche | peprotech | prospec | pierce | BD Pharmingen | BD Biocoat | R&D | BioVision | Vector | Enzo life | eBioscience | ABR | Amresco | Cayman Chemical | 脂蛋白 | Merck | Qiagen(凱杰) | Santa cruz(三塔抗體) |
產品名稱:Anti-Human CD319 (CRACC) PE (162) 25 tests
產品貨號:eBioscience 12-2229-41
產品規格:25 tests
Anti-Human CD319 (CRACC) PE
Also known as: CD2 like Receptor activating cytotoxic cells, CS1, SLAMF7
Clone: 162
RUO: For Research Use Only. Not for use in diagnostic procedures.
SKU# 12-2229
Cat. No. Size
12-2229-41 25 tests
12-2229-42 100 tests
Description: The monoclonal antibody 162 recognizes CRACC (CD2 like receptor for activating cytotoxic cells) also known as CD319 and CS1. It is a member of the SLAM receptor family. CRACC is a 66kDa glycosylated transmembrane protein which contains a cytoplasmic ITSM domain (Immunoreceptor Tyrosine-based Switch Motif). It is this domain, found in other proteins such as CD244 and NTB-A, that interacts with SH2 containing proteins such as SAP. Interestingly the ITSM domain in CRACC is SAP independent. Instead EAT-2 acts as the signaling molecule for CRACC. This has profound impact for patients with X-linked lymphoproliferative disease (contains a SAP mutation). It should be noted that a splice variant has been reported which deletes the ITSM domain.